Skip to main content

Overview

SEC Filings Details

Quarterly Results
SEC Filings

8-K

January 26, 2026

Current report filing

Download / View Download / View, 8-K, Current report filing, January 26, 2026, pdf format, opens in new window Download / View, 8-K, Current report filing, January 26, 2026, zip format, opens in new window Download / View, 8-K, Current report filing, January 26, 2026, html format, opens in new window Download / View, 8-K, Current report filing, January 26, 2026, excel format, opens in new window

Investor Contacts

Andrew McKibben

650-667-4085
ir@mirumpharma.com

Media Contact

Meredith Kiernan

media@mirumpharma.com

Investor Email Alerts

Personal Information.

Email Address *Required Email Address is required. Email Address is invalid.

Investor Alert Options *

News
Quarterly Reports
Annual Reports
SEC Filings
End of Day Stock Quote
Events & Presentations

Investor Alert Options is required.

The captcha test has failed. Please try again.

© 2026 Mirum Pharmaceuticals, Inc. - All rights reserved

Powered By Q4 Inc. 5.177.0.3 (opens in new window)

Privacy Policy opens in new window
Terms of Use opens in new window
Contact Us opens in new window
CA TISCAD opens in new window